Jaguar Health, Inc.
JAGX
$1.76
-$0.03-1.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.98M | 2.21M | 3.51M | 3.11M | 2.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.98M | 2.21M | 3.51M | 3.11M | 2.72M |
| Cost of Revenue | 527.00K | 515.00K | 557.00K | 541.00K | 427.00K |
| Gross Profit | 2.45M | 1.70M | 2.95M | 2.57M | 2.29M |
| SG&A Expenses | 7.19M | 7.39M | 6.58M | 5.79M | 5.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.99M | 11.64M | 11.67M | 10.37M | 9.92M |
| Operating Income | -8.01M | -9.42M | -8.16M | -7.26M | -7.20M |
| Income Before Tax | -10.56M | -10.60M | -10.23M | -10.02M | -9.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.56M | -10.60M | -10.23M | -10.02M | -9.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 153.00K | 132.00K | 314.00K | 167.00K | 136.00K |
| Net Income | -10.41M | -10.46M | -9.92M | -9.85M | -9.49M |
| EBIT | -8.01M | -9.42M | -8.16M | -7.26M | -7.20M |
| EBITDA | -7.53M | -8.94M | -7.68M | -6.79M | -6.75M |
| EPS Basic | -10.26 | -16.70 | -20.83 | -26.29 | -2.66 |
| Normalized Basic EPS | -5.23 | -10.36 | -12.77 | -16.26 | -1.65 |
| EPS Diluted | -10.26 | -16.70 | -20.83 | -26.29 | -2.66 |
| Normalized Diluted EPS | -5.23 | -10.36 | -12.77 | -16.26 | -1.65 |
| Average Basic Shares Outstanding | 1.01M | 626.60K | 476.30K | 374.80K | 3.57M |
| Average Diluted Shares Outstanding | 1.01M | 626.60K | 476.30K | 374.80K | 3.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |